Sign up

Parkman Healthcare Partners LLC

$973.7M assets · 76 holdings · Q2 2026 · Filed 14 AUG 2026

About Parkman Healthcare Partners LLC’s 13F portfolio

Parkman Healthcare Partners LLC is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Parkman Healthcare Partners LLC reported $973.7M across 76 US-listed positions (). Its largest position is MBX BIOSCIENCES INC (MBX) at 4.5% of the reported book, and its ten biggest holdings make up 34% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.

$973.7M
Assets (13F)
#2,413
of 8,845 by size
76
Holdings
34%
Top-10 weight
44
Buys
60
Sells
Top holdings · Q2 2026
76 total
#StockPrice% of portfolioSharesValue
1
NASDAQ: MBX
MBX BIOSCIENCES INC
$49.55
−7.23%
4.5%
800K$44.2M
2
NYSE: LLY
ELI LILLY & CO
$1,347.11
−0.30%
4.3%
35K$42.0M
3
NYSE: CVS
CVS HEALTH CORP
$80.84
+1.00%
4.2%
392K$40.5M
4
NASDAQ: DXCM
DEXCOM INC
$79.32
−1.08%
3.7%
535K$36.0M
5
NASDAQ: PTCT
PTC THERAPEUTICS INC
$56.42
−3.27%
3.6%
436K$35.5M
6
NYSE: RCUS
ARCUS BIOSCIENCES INC
$15.62
−1.01%
2.9%
919K$28.3M
7
NASDAQ: GPCR
STRUCTURE THERAPEUTICS INC
$16.13
−5.78%
2.7%
486K$26.1M
8
NASDAQ: VRDN
VIRIDIAN THERAPEUTICS INC
$29.96
−4.71%
2.6%
1.4M$25.3M
9
NASDAQ: AGIO
AGIOS PHARMACEUTICALS INC
$27.60
−4.03%
2.5%
669K$24.8M
10
NASDAQ: INBX
INHIBRX BIOSCIENCES INC
$68.97
−7.21%
2.5%
257K$24.3M
11
NASDAQ: XENE
XENON PHARMACEUTICALS INC
$37.04
−1.38%
2.5%
397K$24.0M
12
NASDAQ: EWTX
EDGEWISE THERAPEUTICS INC
$39.91
−3.07%
2.4%
577K$23.4M
13
NYSE: UNH
UNITEDHEALTH GROUP INC
$339.85
+2.84%
2.4%
56K$23.2M
14
NYSE: SYK
STRYKER CORPORATION
$310.00
−0.98%
2.2%
68K$21.4M
15
NYSE: IQV
IQVIA HLDGS INC
$245.82
−1.89%
2.1%
106K$20.4M
16
NYSE: ZBH
ZIMMER BIOMET HOLDINGS INC
$101.10
−0.36%
2.1%
233K$20.0M
17
NASDAQ: PODD
INSULET CORP
$133.17
−2.96%
2.1%
131K$20.0M
18
NASDAQ: ASMB
ASSEMBLY BIOSCIENCES INC
$22.19
−1.38%
2.0%
721K$19.8M
19
NASDAQ: SNDX
SYNDAX PHARMACEUTICALS INC
$8.72
−4.49%
2.0%
877K$19.2M
20
NASDAQ: EYPT
EYEPOINT INC
$0.23
−11.36%
1.9%
1.3M$18.4M
21
NYSE: THC
TENET HEALTHCARE CORP
$263.19
−0.15%
1.9%
97K$18.2M
22
NASDAQ: LIVN
LIVANOVA PLC
$90.73
−1.46%
1.8%
211K$17.3M
23
NASDAQ: ANIP
ANI PHARMACEUTICALS INC
$68.55
−0.84%
1.7%
203K$16.8M
24
NASDAQ: BCRX
BIOCRYST PHARMACEUTICALS INC
$7.22
−1.37%
1.7%
1.6M$16.2M
25
NASDAQ: ALNY
ALNYLAM PHARMACEUTICALS INC
$143.82
−2.71%
1.6%
51K$15.3M

Showing 1–25 of 76 positions on this page reported in this 13F.

Sector allocation
  • Healthcare98%
  • Industrials0.8%
Recent activity · vs 2026-03-31
Bought44
  • AddedMBXMBX BIOSCIENCES INC+0.0%$44.2M
  • AddedLLYELI LILLY & CO+1.1%$42.0M
  • AddedCVSCVS HEALTH CORP+1.2%$40.5M
  • AddedPTCTPTC THERAPEUTICS INC+1.0%$35.5M
  • AddedGPCRSTRUCTURE THERAPEUTICS INC+109%$26.1M
  • AddedVRDNVIRIDIAN THERAPEUTICS INC+147%$25.3M
  • AddedAGIOAGIOS PHARMACEUTICALS INC+65.8%$24.8M
  • NewINBXINHIBRX BIOSCIENCES INC—$24.3M
  • AddedEWTXEDGEWISE THERAPEUTICS INC+78.7%$23.4M
  • NewUNHUNITEDHEALTH GROUP INC—$23.2M
Sold60
  • ReducedDXCMDEXCOM INC−22.5%$36.0M
  • ReducedRCUSARCUS BIOSCIENCES INC−23.9%$28.3M
  • ReducedXENEXENON PHARMACEUTICALS INC−20.1%$24.0M
  • ReducedSYKSTRYKER CORPORATION−56.1%$21.4M
  • ReducedZBHZIMMER BIOMET HOLDINGS INC−13.7%$20.0M
  • ReducedPODDINSULET CORP−16.1%$20.0M
  • ReducedSNDXSYNDAX PHARMACEUTICALS INC−2.7%$19.2M
  • ReducedEYPTEYEPOINT INC−4.9%$18.4M
  • ReducedLIVNLIVANOVA PLC−47.9%$17.3M
  • ReducedANIPANI PHARMACEUTICALS INC−27.7%$16.8M
5%+ Beneficial Ownership Stakes · 1 passive (13G)

Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.

#StockType% of classSharesFiled
1
ALGS
Aligos Therapeutics, Inc.
13G5.2%326KFiled 13 NOV 2026

Showing all 1 disclosed stakes.

Reading Parkman Healthcare Partners LLC’s 13F portfolio

Parkman Healthcare Partners LLC’s $973.7M 13F book is spread across 76 reported positions and is moderately diversified, the ten largest names accounting for 34%. There are meaningful positions at the top alongside a long tail of smaller holdings. Its five largest positions are MBX, LLY, CVS, DXCM and PTCT, led by MBX BIOSCIENCES INC (MBX) at 4.5% of the portfolio. The heaviest sector exposure is Healthcare (98%), then Industrials (1%).

What Parkman Healthcare Partners LLC changed last quarter

Between 2026-03-31 and Q2 2026, Parkman Healthcare Partners LLC was a net seller: it opened 17 new positions and added to 27 more, while trimming 30 and closing 30 outright. Against a 76-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was MBX BIOSCIENCES INC (MBX), and its biggest reduction was DEXCOM INC (DXCM).

What a 13F does and doesn’t reveal

A 13F captures only Parkman Healthcare Partners LLC’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Parkman Healthcare Partners LLC is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.

Frequently asked questions

What is an SEC 13F filing?

A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Parkman Healthcare Partners LLC's profile on this page is built directly from those filings.

How current is the 13F data on Parkman Healthcare Partners LLC's page?

It reflects Parkman Healthcare Partners LLC's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Parkman Healthcare Partners LLC files its next quarterly report, this page refreshes automatically.

Can I see Parkman Healthcare Partners LLC's complete list of holdings?

This page highlights Parkman Healthcare Partners LLC's largest positions rather than all 76 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Parkman Healthcare Partners LLC's filings.

Does a 13F show everything Parkman Healthcare Partners LLC owns?

No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Parkman Healthcare Partners LLC's book rather than its full strategy or total assets.

Is 13F data investment advice?

No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Parkman Healthcare Partners LLC made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.

Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.